Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-23-160848
Filing Date
2023-06-05
Accepted
2023-06-05 17:31:29
Documents
8
Effectiveness Date
2023-06-05

Document Format Files

Seq Description Document Type Size
1 S-8 d401818ds8.htm S-8 43041
2 EX-4.4 d401818dex44.htm EX-4.4 97354
3 EX-4.5 d401818dex45.htm EX-4.5 58492
4 EX-5.1 d401818dex51.htm EX-5.1 5005
5 EX-23.1 d401818dex231.htm EX-23.1 1675
6 EX-FILING FEES d401818dexfilingfees.htm EX-FILING FEES 18581
7 GRAPHIC g401818g0602225556902.jpg GRAPHIC 5696
8 GRAPHIC g401818g0602225557027.jpg GRAPHIC 4498
  Complete submission text file 0001193125-23-160848.txt   239511
Mailing Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879
Business Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879 240-631-3200
Emergent BioSolutions Inc. (Filer) CIK: 0001367644 (see all company filings)

EIN.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-272433 | Film No.: 23994004
SIC: 2834 Pharmaceutical Preparations